| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.27 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |